Matt Hewitt
Stock Analyst at Craig-Hallum
(2.62)
# 2,067
Out of 5,142 analysts
43
Total ratings
54.05%
Success rate
2.66%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $45 → $36 | $11.43 | +214.96% | 8 | Jun 13, 2025 | |
| CSBR Champions Oncology | Maintains: Buy | $8 → $12 | $5.90 | +103.39% | 4 | Mar 12, 2025 | |
| CLOV Clover Health Investments | Initiates: Buy | $6 | $1.98 | +203.03% | 1 | Dec 17, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $22.91 | +39.68% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $39.56 | +61.78% | 6 | Oct 31, 2024 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $135 → $140 | $183.13 | -23.55% | 3 | Jul 9, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $0.27 | +3,552.30% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $11.22 | +167.38% | 3 | May 2, 2024 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $0.75 | +830.48% | 1 | Nov 29, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $135.35 | +47.77% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.71 | +484.80% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $4.56 | +557.89% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $0.24 | +164,848.45% | 1 | Jan 4, 2022 |
Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45 → $36
Current: $11.43
Upside: +214.96%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $5.90
Upside: +103.39%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $1.98
Upside: +203.03%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $22.91
Upside: +39.68%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $39.56
Upside: +61.78%
Ligand Pharmaceuticals
Jul 9, 2024
Maintains: Buy
Price Target: $135 → $140
Current: $183.13
Upside: -23.55%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $0.27
Upside: +3,552.30%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $11.22
Upside: +167.38%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $0.75
Upside: +830.48%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $135.35
Upside: +47.77%
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.71
Upside: +484.80%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $4.56
Upside: +557.89%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $0.24
Upside: +164,848.45%